Skip to main content

Prototype Prescribing Outlier Dashboard for The Marshside Surgery

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where The Marshside Surgery is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Spironolactone with loop diuretics 5 Potassium sparing diuretics and compounds 9 0.56 0.01 0.08 7.22
Aluminium and magnesium and oxetacaine 10 Antacids and simeticone 10 1.00 0.04 0.15 6.42
Levocetirizine 29 Antihistamines 500 0.06 0.00 0.01 6.21
Co-fluampicil(Flucloxacillin/ampicillin) 2 Broad-spectrum penicillins 364 0.01 0.00 0.00 5.77
Chloroquine phosphate 5 Antimalarials 186 0.03 0.00 0.00 5.53
Loprazolam mesilate 10 Hypnotics 279 0.04 0.00 0.01 5.22
Eprosartan 20 Angiotensin-II receptor antagonists 688 0.03 0.00 0.01 5.01
Febuxostat 38 Gout and cytotoxic induced hyperiuicaemia 254 0.15 0.02 0.03 4.61
Colestipol hydrochloride 4 Lipid-regulating drugs 3,271 0.00 0.00 0.00 4.43
Mupirocin 14 Nasal preparations for infection 19 0.74 0.16 0.14 4.20

Prescribing where The Marshside Surgery is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Neomycin sulfate 5 Nasal preparations for infection 19 0.26 0.84 0.14 -4.20
Macrogol 3350 193 Osmotic laxatives 408 0.47 0.71 0.10 -2.42
Ramipril 603 Angiotensin-converting enzyme inhibitors 1,722 0.35 0.69 0.17 -2.08
Latanoprost 77 Treatment of glaucoma 524 0.15 0.31 0.08 -1.95
Carbimazole 22 Antithyroid drugs 30 0.73 0.93 0.10 -1.92
Zinc sulfate monohydrate 0 Zinc 12 0.00 0.74 0.39 -1.90
    Levothyroxine sodium 1,195 Thyroid hormones 1,203 0.99 1.00 0.00 -1.77
    Allopurinol 205 Gout and cytotoxic induced hyperiuicaemia 254 0.81 0.90 0.05 -1.74
    Naftidrofuryl oxalate 0 Peripheral vasodilators and related drugs 4 0.00 0.67 0.39 -1.73
      Rivaroxaban 40 Oral anticoagulants 921 0.04 0.24 0.12 -1.65